MedTrace Logo

Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects

NCT02609711 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-11-20

No results posted yet for this study

Summary

primary object : Evaluate pharmacokinetic drug-drug interaction of Candesartan and Atorvastatin

Conditions

  • Healthy Male Subjects

Interventions

DRUG

Candesartan cilexetil

Sponsors & Collaborators

  • Ahn-Gook Pharmaceuticals Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Chul Woo Kim · INHA UNIV. HOSPITAL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02609711 on ClinicalTrials.gov